Cooperative Agreement HT94252520005
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$6.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Cooperative Agreement
Place of Performance
Houston, TX 77204, USA
Similar Awards
The University of Houston System was awarded a $999,392 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on PRMT5 in lupus nephritis, with a project period running through August 31, 2029. As a prominent research institution, the...
The University of Houston System was awarded a $999,465 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of selective spleen-targeted nanoparticles as drug delivery vehicles for the treatment of lupus. This research aims to transform healthcare for military service members and the broader public by advancing innovative biomedical solutions. The program...
This Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $19,100,256 to The University of Texas MD Anderson Cancer Center in Houston, TX over a 4-year period from August 1, 2025 to July 31, 2029. The purpose of the award is to support the "CONVERGENT SCIENCE CANCER CONSORTIUM FOR IMMUNE CELL ENGINEERING" which aims to advance biomedical research and transform healthcare for military service...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...
The University of Houston System, a Hispanic-Serving Institution, was awarded a $1,101,840 federal Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on January 1, 2024, supports a research project titled "INVESTIGATING NEBIVOLOL IN TRIPLE-NEGATIVE BREAST CANCER" to be completed by December 31, 2026. The project aims to develop new treatments and advance scientific understanding of military health...
The University of Houston System was awarded a $796,968 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering fields contributing to defense technology development. The grant is part of the Department of Defense's Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) and will fund research from June 1, 2023 through May 31, 2027. As a Hispanic Serving Institution, the University of...
The University of Houston System, doing business as the University of Houston, received a $217,836 Project Grant award from the Department of the Army Materiel Command Research Development and Engineering Command. The award supports basic research related to or with the potential to improve Army programs or operations, as part of the Basic Scientific Research federal grant program (CFDA 12.431). The funding will enable the University to conduct research to develop scientific understanding and...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
The federal Project Grant award of $1,496,576.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Baylor College of Medicine in Houston, Texas, aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational domains, will focus on innovative investigations across multiple medical...
This Project Grant award, valued at $750,000.00, was issued on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Houston System to investigate "Circulating Immune Complexes as Biomarkers for Early Detection and Monitoring of Ovarian Cancer." The research aims to transform healthcare for military service members, veterans, and the broader public through innovative...